|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2014, inter alia, to consider:
1. Audited Financial Results of the Company for the year ended March 31, 2014.
2. Recommendation of Dividend for the Year ended March 31, 2014.
Further, as per the Company’s Insider Trading Code, the trading window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees of the Company from May 19, 2014 to May 27, 2014 (both days inclusive). |
|
|